250 related articles for article (PubMed ID: 4082630)
21. The hepatic metabolism and biliary excretion of benzo[a]pyrene in guinea-pigs fed normal, high-fat or high-cholesterol diets.
Bowes SG; Renwick AG
Xenobiotica; 1986 Jun; 16(6):531-42. PubMed ID: 3751110
[TBL] [Abstract][Full Text] [Related]
22. Characterization of mutagenic glucuronide formation from benzo(a)pyrene in the nonrecirculating perfused rat liver.
Kari FW; Kauffman FC; Thurman RG
Cancer Res; 1984 Nov; 44(11):5073-8. PubMed ID: 6488167
[TBL] [Abstract][Full Text] [Related]
23. Prostaglandin synthetase and cytochrome P-450-dependent metabolism of (+/-)benzo(a)pyrene 7,8-dihydrodiol by enriched populations of rat Clara cells and alveolar type II cells.
Sivarajah K; Jones KG; Fouts JR; Devereux T; Shirley JE; Eling TE
Cancer Res; 1983 Jun; 43(6):2632-6. PubMed ID: 6303564
[TBL] [Abstract][Full Text] [Related]
24. Uptake and excretion of benzo[a]pyrene and its metabolites by the rat pancreas.
Iqbal ZM; Yoshida A; Epstein SS
Drug Metab Dispos; 1979; 7(1):44-8. PubMed ID: 35326
[TBL] [Abstract][Full Text] [Related]
25. The metabolism and excretion of styrene oxide-glutathione conjugates in the rat and by isolated perfused liver, lung and kidney preparations.
Steele JW; Yagen B; Hernandez O; Cox RH; Smith BR; Bend JR
J Pharmacol Exp Ther; 1981 Oct; 219(1):35-41. PubMed ID: 7288613
[TBL] [Abstract][Full Text] [Related]
26. Mutagenicity and cytotoxicity of benzo(a)pyrene benzo-ring epoxides.
Wood AW; Wislocki PG; Chang RL; Levin W; Lu AY; Yagi J; Hernandez O; Herina DM; Conney AH
Cancer Res; 1976 Sep; 36(9 pt.1):3358-66. PubMed ID: 788899
[TBL] [Abstract][Full Text] [Related]
27. Identification of the glucuronide and glutathione conjugates of the antitumor drug N2-methyl-9-hydroxyellipticinium acetate (Celiptium). Comparative disposition of this drug with its olivacinium isomer in rat bile.
Maftouh M; Monsarrat B; Rao RC; Meunier B; Paoletti C
Drug Metab Dispos; 1984; 12(1):111-9. PubMed ID: 6141901
[TBL] [Abstract][Full Text] [Related]
28. Enterohepatic circulation of T-2 toxin metabolites in the rat.
Coddington KA; Swanson SP; Hassan AS; Buck WB
Drug Metab Dispos; 1989; 17(6):600-5. PubMed ID: 2575494
[TBL] [Abstract][Full Text] [Related]
29. Potent mammary carcinogenicity in female CD rats of a fjord region diol-epoxide of benzo[c]phenanthrene compared to a bay region diol-epoxide of benzo[a]pyrene.
Hecht SS; el-Bayoumy K; Rivenson A; Amin S
Cancer Res; 1994 Jan; 54(1):21-4. PubMed ID: 8261440
[TBL] [Abstract][Full Text] [Related]
30. Metabolism and DNA binding of benzo(a)pyrene in vivo in the rat.
Boroujerdi M; Kung H; Wilson AG; Anderson MW
Cancer Res; 1981 Mar; 41(3):951-7. PubMed ID: 7459882
[No Abstract] [Full Text] [Related]
31. Inhibition of glucuronidation of benzo(a)pyrene phenols by long-chain fatty acids.
Zhong Z; Kauffman FC; Thurman RG
Cancer Res; 1991 Sep; 51(17):4511-5. PubMed ID: 1908348
[TBL] [Abstract][Full Text] [Related]
32. Quantitative significance of glutathione and glutathione-S-transferase in regulating benzo[a]pyrene anti diol-epoxide level in reconstituted C3H/10T1/2 cell lysates, and comparison to rat liver.
Ho D; Fahl WE
Carcinogenesis; 1984 Feb; 5(2):143-8. PubMed ID: 6321048
[TBL] [Abstract][Full Text] [Related]
33. The fate of diastereomeric glutathione conjugates of alpha-bromoisovalerylurea in blood in the rat in vivo and in the perfused liver. Stereoselectivity in biliary and urinary excretion.
Polhuijs M; Meijer DK; Mulder GJ
J Pharmacol Exp Ther; 1991 Feb; 256(2):458-61. PubMed ID: 1993989
[TBL] [Abstract][Full Text] [Related]
34. Tumorigenicity studies with diol-epoxides of benzo(a)pyrene which indicate that (+/-)-trans-7beta,8alpha-dihydroxy-9alpha,10alpha-epoxy-7,8,9,10-tetrahydrobenzo(a)pyrene is an ultimate carcinogen in newborn mice.
Kapitulnik J; Wislocki PG; Levin W; Yagi H; Jerina DM; Conney AH
Cancer Res; 1978 Feb; 38(2):354-8. PubMed ID: 620406
[TBL] [Abstract][Full Text] [Related]
35. Nonenzymatic reduction of benzo(a)pyrene diol-epoxides to trihydroxypentahydrobenzo(a)pyrenes by reduced nicotinamide adenine dinucleotide phosphate.
Yang SK; Gelboin HV
Cancer Res; 1976 Nov; 36(11 Pt 1):4185-9. PubMed ID: 10078
[TBL] [Abstract][Full Text] [Related]
36. Characterization of the biliary and urinary glutathione and N-acetylcysteine metabolites of the hepatic carcinogen 1'-hydroxysafrole and its 1'-oxo metabolite in rats and mice.
Fennell TR; Miller JA; Miller EC
Cancer Res; 1984 Aug; 44(8):3231-40. PubMed ID: 6744260
[TBL] [Abstract][Full Text] [Related]
37. Metabolic activation of benzo(a)pyrene and binding to DNA in cultured human bronchus.
Yang SK; Gelboin HV; Trump BF; Autrup H; Harris CC
Cancer Res; 1977 Apr; 37(4):1210-5. PubMed ID: 844046
[TBL] [Abstract][Full Text] [Related]
38. [Selective inhibition of the fluorescence of benzo(a)pyrene and a mutagenic diol-epoxide derivative in living cells by liposoluble iodinated hydrocarbons].
Deumié M; Bartholomew JC; Wade CG
C R Seances Acad Sci D; 1980 Jun; 290(22):1417-20. PubMed ID: 6772331
[TBL] [Abstract][Full Text] [Related]
39. Nuclear uptake and subsequent nuclear metabolism of benzo(a)pyrene complexed to cytosolic proteins.
Holder GM; Tierney B; Bresnick E
Cancer Res; 1981 Nov; 41(11 Pt 1):4408-14. PubMed ID: 6272976
[TBL] [Abstract][Full Text] [Related]
40. Metabolism of benzo[a]pyrene and (-)-trans-benzo[a]pyrene-7,8-dihydrodiol by freshly isolated hepatocytes from mirror carp.
Zaleski J; Steward AR; Sikka HC
Carcinogenesis; 1991 Feb; 12(2):167-74. PubMed ID: 1995182
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
